Home eMed eMed : Article 419 results found Filter Options Items/Page --select -- 10 25 50 Previous12345678910111213141516Next Type Articles Audio Blog Book File Links Videos Title Author Date Weekly Wisdom from Kauffman: How entrepreneurs can improve productivity and quality in healthcare Christina Sherwood 3/21/2013 Blog Resource Summary: With U.S. healthcare costs rising about 2.5 percent faster than inflation, there’s an urgent need to improve productivity and quality in American healthcare. A Kauffman Foundation report found that open access to medical data could help find that cost-benefit balance. Read More Funding Sources for Life Science Startups Christina Sherwood 3/20/2013 Article Resource Summary: Bringing a healthcare drug or device to market requires an intense amount of capital. Federal regulation in the United States, Europe and beyond requires clinical testing and trials, as well as large sales staffs and other expenses. The early requirements for investing can force entrepreneurs to seek private, dilutive investing and rapidly cut into the amount of ownership of the company by the entrepreneur. Read More Atul Butte: Biotechnology entrepreneur on success and failure Christina Sherwood 3/19/2013 Blog Resource Summary: As a biomedical informatics researcher and biotechnology entrepreneur in the Silicon Valley, Atul Butte has big ideas for the future of life science entrepreneurship. His Butte Lab works to solve genomic medicine problems through new developments in translational bioinformatics. Read More Weekly Wisdom from Kauffman: Startup Visas for foreign-born entrepreneurs could jumpstart economy Christina Sherwood 3/14/2013 Blog Resource Summary: With Washington buzzing about the possibility of comprehensive immigration reform this year, a new Kauffman Foundation white paper showed how Startup Visas for foreign-born entrepreneurs could help jumpstart the economy. Read More Why startups have to pitch attorneys like investors (video) Chris Seper 3/14/2013 Blog Resource Summary: Startups are not just a risk for investors. They are also a risk for the attorneys and other service providers that choose to work with them. That's because there's no guarantee an early-stage company will be around to pay a law firm for all the work it's done - let alone become a long-term customer. Read More Morpheus Medical: Co-founder shares insights on securing funding and managing costs Christina Sherwood 3/12/2013 Blog Resource Summary: With the goal of revolutionizing cardiac MRI, Morpheus Medical has developed software that takes the process from three hours to about 20 minutes. The company was launched about a year and a half ago when entrepreneurs who wanted to use computational processing to help with the diagnosis of disease came together with radiologists from Stanford University to commercialize the product. Read More Weekly Wisdom from Kauffman: Immigrant scientists help to improve cancer survival rates Christina Sherwood 3/7/2013 Blog Resource Summary: With immigrants in more than 40 percent of the cancer researcher slots at America’s top cancer institutes, these scientists are playing an integral role in improving cancer survival rates in the United States, according to a Kauffman Foundation-funded National Foundation for American Policy report released last month. Read More Weekly Wisdom from Kauffman: America’s high-growth health and drug companies reside in some unexpected locales Christina Sherwood 2/28/2013 Blog Resource Summary: More than 6 percent of Inc. 500 firms work in the health and drug space, making it the No. 5 industrial sector for these fast-growing companies from 2005 to 2010. But these medical innovators aren’t all concentrated in the Silicon Valley. Read More Weekly Wisdom from Kauffman: Breaking Down Barriers to Life Sciences Commercialization Christina Sherwood 2/21/2013 Blog Resource Summary: Because life sciences entrepreneurship thrives on harnessing new technologies, spurring innovation, and growing companies, the Kauffman Foundation met in 2003 with the Panel of Advisors on the Life Sciences to help advance those goals. Read More O'Brien: Finding Startup Success as a Physician-Inventor Far From Healthcare Hotspots 2/19/2013 Blog Resource Summary: Dr. Todd O’Brien has additional challenges beyond those encountered by most startup life science CEOs. The 48-year-old podiatrist still sees patients even while developing his latest innovation: an electronic tuning fork for measuring diabetes-related nerve damage in people’s feet. He's also building his company in Orono, Maine - far from any major healthcare hub. Read More Previous12345678910111213141516Next